Penn Medicine Head and Neck Cancer Service Line COVID-19 management guidelines.
Ambulatory Care
/ standards
Betacoronavirus
COVID-19
Combined Modality Therapy
Continuity of Patient Care
/ standards
Coronavirus Infections
/ diagnosis
Head and Neck Neoplasms
/ diagnosis
Humans
Infection Control
/ standards
Medical Oncology
/ standards
Multi-Institutional Systems
Otorhinolaryngologic Surgical Procedures
/ standards
Palliative Care
/ standards
Pandemics
/ prevention & control
Patient Safety
Pennsylvania
Personal Protective Equipment
Pneumonia, Viral
/ diagnosis
SARS-CoV-2
Terminal Care
/ standards
Tertiary Care Centers
COVID-19
SARS-CoV-2
coronavirus
head and neck cancer
Journal
Head & neck
ISSN: 1097-0347
Titre abrégé: Head Neck
Pays: United States
ID NLM: 8902541
Informations de publication
Date de publication:
Jul 2020
Jul 2020
Historique:
received:
06
05
2020
accepted:
20
05
2020
pubmed:
26
6
2020
medline:
21
7
2020
entrez:
26
6
2020
Statut:
ppublish
Résumé
The COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) virus has altered the health care environment for the management of head and neck cancers. The purpose of these guidelines is to provide direction during the pandemic for rational Head and Neck Cancer management in order to achieve a medically and ethically appropriate balance of risks and benefits. Creation of consensus document. The process yielded a consensus statement among a wide range of practitioners involved in the management of patients with head and neck cancer in a multihospital tertiary care health system. These guidelines support an ethical approach for the management of head and neck cancers during the COVID-19 epidemic consistent with both the local standard of care as well as the head and neck oncological literature.
Identifiants
pubmed: 32584447
doi: 10.1002/hed.26318
pmc: PMC7362039
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1507-1515Informations de copyright
© 2020 Wiley Periodicals, Inc.
Références
Head Neck. 2020 Jun;42(6):1268-1272
pubmed: 32333619
Cancer. 2018 Apr 1;124(7):1400-1414
pubmed: 29315499
Dis Colon Rectum. 2020 Jun;63(6):720-722
pubmed: 32384401
Head Neck. 2020 Jun;42(6):1131-1136
pubmed: 32298006
Cancer. 2019 Feb 1;125(3):406-415
pubmed: 30341983
J Med Virol. 1991 Jan;33(1):47-50
pubmed: 1901908
Surg Oncol Clin N Am. 2015 Jul;24(3):491-508
pubmed: 25979396
Cancer. 2015 Apr 15;121(8):1204-13
pubmed: 25490875
Mucosal Immunol. 2016 Jul;9(4):1089-101
pubmed: 26647718
JAMA Oncol. 2019 Jun 1;5(6):801-809
pubmed: 30870556
Head Neck. 2020 Jun;42(6):1339-1343
pubmed: 32343454
J Am Acad Dermatol. 1989 Jul;21(1):41-9
pubmed: 2545749
Ann Surg. 2020 Jul;272(1):e30-e32
pubmed: 32379079
J Natl Cancer Inst. 2019 May 1;111(5):490-497
pubmed: 30239887
Int Forum Allergy Rhinol. 2020 Apr 23;:
pubmed: 32323923
Curr Opin Oncol. 2017 Mar 1;:
pubmed: 28252460
Radiother Oncol. 2009 Jul;92(1):4-14
pubmed: 19446902
Int Forum Allergy Rhinol. 2020 Jul;10(7):798-805
pubmed: 32243678
Cancer. 2013 Sep 15;119(18):3302-8
pubmed: 23797868
EClinicalMedicine. 2020 Apr 5;:100331
pubmed: 32292899
Head Neck. 2020 Jul;42(7):1507-1515
pubmed: 32584447
J Clin Oncol. 2011 Nov 10;29(32):4294-301
pubmed: 21969503
Ann Surg. 2020 Apr 17;:
pubmed: 32379080
Science. 2020 May 1;368(6490):489-493
pubmed: 32179701
Head Neck. 2020 Feb 24;:
pubmed: 32092220
Head Neck. 2020 Jun;42(6):1273-1277
pubmed: 32298017
Cancer. 2012 Jul 15;118(14):3519-30
pubmed: 22086669
J Clin Oncol. 2008 Jul 20;26(21):3582-9
pubmed: 18559875
J Surg Oncol. 2016 Sep;114(4):405-11
pubmed: 27392812
Int Forum Allergy Rhinol. 2019 Jul;9(S3):S145-S365
pubmed: 31329374
Head Neck. 2020 Jul;42(7):1497-1502
pubmed: 32415891
N Engl J Med. 2020 Apr 16;382(16):1564-1567
pubmed: 32182409
J Clin Oncol. 2016 Jan 10;34(2):169-78
pubmed: 26628469